Back to results
US 11,453,907 B2Granted
Crispr effector system based coronavirus diagnostics
AssigneesThe Broad Institute, Inc., Massachusetts Institute of Technology
InventorsFeng Zhang, Jonathan Gootenberg, Omar Abudayyeh, Julia Joung, Alim Ladha, Han Altae-Tran, Guilhem Faure
Life of this patent
Estimating the term…
Abstract
Systems and methods for rapid diagnostics related to the use of CRISPR effector systems and optimized guide sequences for detection of coronavirus, including multiplex lateral flow diagnostic devices and methods of use, are provided.
Claims13
A single reaction composition for detecting the presence of a target polynucleotide in a crude or unprocessed sample, comprising:
- a DNA isolation solution capable of isolating target RNA from the crude or unprocessed sample comprising a cell or virus containing a target RNA;
- one or more thermostable Cas proteins possessing collateral activity;
- at least one guide polynucleotide comprising a sequence capable of binding the target RNA and designed to form a CRISPR-Cas complex with the one or more Cas proteins;
- isothermal amplification reagents comprising optimized loop-mediated isothermal amplification (LAMP) primers and amplification reagents;
- and
- a detection construct comprising a polynucleotide component, wherein the one or more Cas proteins exhibit collateral nuclease activity and cleave the polynucleotide component of the detection construct once activated by the target RNA, thereby generating a detectable signal.
3 more elements
Dependencies are inferred from the claim text.